The Korea Times
amn_close.png
amn_bl.png
National
  • Politics
  • Foreign Affairs
  • Multicultural Community
  • Defense
  • Environment & Animals
  • Law & Crime
  • Society
  • Health & Science
amn_bl.png
Business
  • Tech
  • Bio
  • Companies
amn_bl.png
Finance
  • Companies
  • Economy
  • Markets
  • Cryptocurrency
amn_bl.png
Opinion
  • Editorial
  • Columns
  • Thoughts of the Times
  • Cartoon
  • Today in History
  • Blogs
  • Tribune Service
  • Blondie & Garfield
  • Letter to President
  • Letter to the Editor
amn_bl.png
Lifestyle
  • Travel & Food
  • Trends
  • People & Events
  • Books
  • Around Town
  • Fortune Telling
amn_bl.png
Entertainment & Arts
  • K-pop
  • Films
  • Shows & Dramas
  • Music
  • Theater & Others
amn_bl.png
Sports
amn_bl.png
World
  • SCMP
  • Asia
amn_bl.png
Video
  • Korean Storytellers
  • POPKORN
  • Culture
  • People
  • News
amn_bl.png
Photos
  • Photo News
  • Darkroom
amn_NK.png amn_DR.png amn_LK.png amn_LE.png
  • bt_fb_on_2022.svgbt_fb_over_2022.svg
  • bt_twitter_on_2022.svgbt_twitter_over_2022.svg
  • bt_youtube_on_2022.svgbt_youtube_over_2022.svg
  • bt_instagram_on_2022.svgbt_instagram_over_2022.svg
The Korea Times
amn_close.png
amn_bl.png
National
  • Politics
  • Foreign Affairs
  • Multicultural Community
  • Defense
  • Environment & Animals
  • Law & Crime
  • Society
  • Health & Science
amn_bl.png
Business
  • Tech
  • Bio
  • Companies
amn_bl.png
Finance
  • Companies
  • Economy
  • Markets
  • Cryptocurrency
amn_bl.png
Opinion
  • Editorial
  • Columns
  • Thoughts of the Times
  • Cartoon
  • Today in History
  • Blogs
  • Tribune Service
  • Blondie & Garfield
  • Letter to President
  • Letter to the Editor
amn_bl.png
Lifestyle
  • Travel & Food
  • Trends
  • People & Events
  • Books
  • Around Town
  • Fortune Telling
amn_bl.png
Entertainment & Arts
  • K-pop
  • Films
  • Shows & Dramas
  • Music
  • Theater & Others
amn_bl.png
Sports
amn_bl.png
World
  • SCMP
  • Asia
amn_bl.png
Video
  • Korean Storytellers
  • POPKORN
  • Culture
  • People
  • News
amn_bl.png
Photos
  • Photo News
  • Darkroom
amn_NK.png amn_DR.png amn_LK.png amn_LE.png
  • bt_fb_on_2022.svgbt_fb_over_2022.svg
  • bt_twitter_on_2022.svgbt_twitter_over_2022.svg
  • bt_youtube_on_2022.svgbt_youtube_over_2022.svg
  • bt_instagram_on_2022.svgbt_instagram_over_2022.svg
  • Login
  • Register
  • Login
  • Register
  • The Korea Times
  • search
  • all menu
  • Login
  • Subscribe
  • Photos
  • Video
  • World
  • Sports
  • Opinion
  • Entertainment & Art
  • Lifestyle
  • Finance
  • Business
  • National
  • North Korea
  • 1

    Kim Min-gyu, Go Bo-gyeol bid farewell to 'The Heavenly Idol'

  • 3

    Han Suk-kyu on return of 'Dr. Romantic' with Season 3

  • 5

    Genesis launches 2023 G90 sedan

  • 7

    Churches, Seoul gov't unite to fight low birthrate

  • 9

    Burnout: Cardiothoracic surgery residents work 102 hours a week

  • 11

    Kakao Entertainment, Colombia Record team up for IVE's North American debut

  • 13

    What's next for Do Kwon?

  • 15

    BTS' Jimin releases solo album

  • 17

    Crypto founder Do Kwon is indicted in US, following Montenegro arrest

  • 19

    Over 70% of firms unwilling to embrace longer workweek

  • 2

    Zoo shares sad story of what caused Sero the zebra to escape

  • 4

    Kim Nam-gil to embark on Asia fan-meeting tour

  • 6

    N. Korea tests 'underwater nuclear attack drone,' cruise missiles for nuclear warhead: KCNA

  • 8

    North Korea will pay price for reckless provocations, warns Yoon

  • 10

    Hybe to sell SM shares to Kakao following failed takeover bid

  • 12

    Kyochon heralds 30,000 won fried chicken era

  • 14

    Second daughter of Daesang chairman promoted to vice president

  • 16

    More companies adopt electronic voting amid increase in shareholder activism

  • 18

    Samsung Electronics chief to attend China Development Forum

  • 20

    Samsung Display strike looms due to deadlocked wage negotiations

Close scrollclosebutton

Close for 24 hours

Open
  • The Korea Times
  • search
  • all menu
  • Login
  • Subscribe
  • Photos
  • Video
  • World
  • Sports
  • Opinion
  • Entertainment & Art
  • Lifestyle
  • Finance
  • Business
  • National
  • North Korea
Finance
  • Companies
  • Economy
  • Markets
  • Cryptocurrency
Sun, March 26, 2023 | 05:35
Economy
Abbott Laboratories ordered to sell vessel closure device biz
Posted : 2016-12-25 16:09
Updated : 2016-12-25 18:51
Yoon Ja-young
Print PreviewPrint Preview
Font Size UpFont Size Up
Font Size DownFont Size Down
  • facebook
  • twitter
  • kakaolink
  • whatsapp
  • reddit
  • mailto
  • link
By Yoon Ja-young

The country's anti-trust agency ordered a global medical device manufacturer to sell part of its assets to address concerns that its acquisition of a competitor would hamper competition in the market.

The Fair Trade Commission (FTC) said Sunday that the acquisition of St. Jude Medical by Abbott Laboratories triggers concern that it could restrict competition in the country's "vessel closure device" market. Vessel closure devices are used to close small holes doctors make in arteries to examine or treat heart and vascular problems.

Abbott Laboratories is a global healthcare and medical device company based in the United States. Medical devices comprise around 25 percent of its total sales, including cardiovascular products as well as optical instruments and products for the treatment of diabetes.

St. Jude Medical, also based in the United States, is a global medical device manufacturer, mostly known for cardiovascular products and devices related to atrial fibrillation.

The two companies are competing with each other in cardiovascular medical devices markets both in Korea and globally.

Abbott signed a deal to acquire St. Jude Medical in April, and notified Korea's FTC of the deal in August. The purchasing price is $25 billion.

The FTC determined that the takeover restricts competition in the country's vessel closure device market, since the market share of the two companies combined stands at 99 percent ― Abbott Laboratories with 58 percent and St. Jude Medical with 41 percent.

"Since products of St. Jude Medical had been pressuring Abbott as a competitor in the market, the takeover will be the end of the two companies' competition, which makes it highly likely that prices will be raised," said Sun Joong-kyu, director in charge of corporate merger at the FTC.

Cardinal Health, which is the third player in the market, has only a 1 percent market share.

"When considering its small market share, Cardinal Health is likely to only follow the price set by the company born through the takeover," he added.

The FTC thus ordered Abbott Laboratories to sell all of its assets as well related with the development, manufacturing or sales of the vessel closure device. This is the first time for the FTC to make an order regarding a corporate takeover in the medical device industry.

The anti-trust agency said that it is fundamentally preventing damage to consumers by maintaining competition in the market.

Emailyjy@ktimes.com Article ListMore articles by this reporter
 
Top 10 Stories
1Zoo shares sad story of what caused Sero the zebra to escape Zoo shares sad story of what caused Sero the zebra to escape
2Genesis launches 2023 G90 sedan Genesis launches 2023 G90 sedan
3Churches, Seoul gov't unite to fight low birthrate Churches, Seoul gov't unite to fight low birthrate
4North Korea will pay price for reckless provocations, warns Yoon North Korea will pay price for reckless provocations, warns Yoon
5Burnout: Cardiothoracic surgery residents work 102 hours a week Burnout: Cardiothoracic surgery residents work 102 hours a week
6Kyochon heralds 30,000 won fried chicken era Kyochon heralds 30,000 won fried chicken era
7What's next for Do Kwon? What's next for Do Kwon?
8Second daughter of Daesang chairman promoted to vice president Second daughter of Daesang chairman promoted to vice president
9More companies adopt electronic voting amid increase in shareholder activism More companies adopt electronic voting amid increase in shareholder activism
10Over 70% of firms unwilling to embrace longer workweek Over 70% of firms unwilling to embrace longer workweek
Top 5 Entertainment News
1Kim Min-gyu, Go Bo-gyeol bid farewell to 'The Heavenly Idol' Kim Min-gyu, Go Bo-gyeol bid farewell to 'The Heavenly Idol'
2Yoo Yeon-seok threatens to sue people spreading accusations about him Yoo Yeon-seok threatens to sue people spreading accusations about him
3Han Suk-kyu on return of 'Dr. Romantic' with Season 3 Han Suk-kyu on return of 'Dr. Romantic' with Season 3
4Kim Nam-gil to embark on Asia fan-meeting tour Kim Nam-gil to embark on Asia fan-meeting tour
5Lee Som, Ahn Jae-hong to play married couple in Tving's new series Lee Som, Ahn Jae-hong to play married couple in Tving's new series
DARKROOM
  • Turkey-Syria earthquake

    Turkey-Syria earthquake

  • Nepal plane crash

    Nepal plane crash

  • Brazil capital uprising

    Brazil capital uprising

  • Happy New Year 2023

    Happy New Year 2023

  • World Cup 2022 Final - Argentina vs France

    World Cup 2022 Final - Argentina vs France

CEO & Publisher : Oh Young-jin
Digital News Email : webmaster@koreatimes.co.kr
Tel : 02-724-2114
Online newspaper registration No : 서울,아52844
Date of registration : 2020.02.05
Masthead : The Korea Times
Copyright © koreatimes.co.kr. All rights reserved.
  • About Us
  • Introduction
  • History
  • Contact Us
  • Products & Services
  • Subscribe
  • E-paper
  • RSS Service
  • Content Sales
  • Site Map
  • Policy
  • Code of Ethics
  • Ombudsman
  • Privacy Statement
  • Terms of Service
  • Copyright Policy
  • Family Site
  • Hankook Ilbo
  • Dongwha Group